Bryn Mawr Capital Management LLC Takes Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Bryn Mawr Capital Management LLC purchased a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) during the fourth quarter, Holdings Channel.com reports. The firm purchased 2,100 shares of the medical instruments supplier’s stock, valued at approximately $203,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Louisiana State Employees Retirement System increased its position in shares of Merit Medical Systems by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 28,200 shares of the medical instruments supplier’s stock worth $2,728,000 after acquiring an additional 100 shares in the last quarter. Tidal Investments LLC increased its holdings in shares of Merit Medical Systems by 1.0% during the 3rd quarter. Tidal Investments LLC now owns 10,398 shares of the medical instruments supplier’s stock valued at $1,028,000 after acquiring an additional 104 shares during the last quarter. Glenmede Trust Co. NA raised its stake in shares of Merit Medical Systems by 0.6% in the 3rd quarter. Glenmede Trust Co. NA now owns 28,637 shares of the medical instruments supplier’s stock valued at $2,830,000 after acquiring an additional 170 shares in the last quarter. Captrust Financial Advisors boosted its position in Merit Medical Systems by 2.6% during the third quarter. Captrust Financial Advisors now owns 7,440 shares of the medical instruments supplier’s stock worth $735,000 after purchasing an additional 187 shares during the period. Finally, GAMMA Investing LLC grew its holdings in Merit Medical Systems by 14.7% during the fourth quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier’s stock valued at $144,000 after purchasing an additional 191 shares during the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Stock Down 1.9 %

MMSI opened at $98.52 on Friday. The company has a market capitalization of $5.74 billion, a P/E ratio of 48.29, a P/E/G ratio of 2.34 and a beta of 0.87. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. The firm’s fifty day moving average price is $102.83 and its two-hundred day moving average price is $99.88. Merit Medical Systems, Inc. has a fifty-two week low of $70.70 and a fifty-two week high of $111.45.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. StockNews.com downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Sunday, November 3rd. Barrington Research lowered their price target on Merit Medical Systems from $115.00 to $111.00 and set an “outperform” rating on the stock in a research report on Wednesday. Piper Sandler reissued an “overweight” rating and set a $116.00 price objective (up previously from $114.00) on shares of Merit Medical Systems in a research report on Wednesday, January 29th. Wells Fargo & Company dropped their price target on Merit Medical Systems from $120.00 to $117.00 and set an “overweight” rating on the stock in a research report on Wednesday. Finally, Canaccord Genuity Group lowered their price objective on shares of Merit Medical Systems from $128.00 to $127.00 and set a “buy” rating on the stock in a research note on Wednesday. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and an average price target of $108.40.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.